Psilera News and Resources

Psilera, Inc., a biotechnology company focused on neurological disorders, has entered into a licensing agreement with atai Life Sciences, a clinical-stage biopharmaceutical company developing psychedelic-based therapies. Under the agreement, atai has acquired Psilera’s patent portfolio covering DMT and related psychedelics. Psilera’s